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account of its particular subject area and is 
therefore a valuable source of reference. 
Articles in most of which the emphasis lies more 
towards the research of the authors include those 
by Robert (Structural Glycoproteins: Historical 
Remarks), Labat-Robert (Structural Glycoproteins 
and Cell-Matrix Interactions in Normal and 
Pathological Conditions), Moczar and Lafuma 
(Structural Glycoproteins from Aorta and Lung), 
Hornebeck and Robert (Interactions between 
Elastic Fibres and Cells), Lesot (Cell-Matrix In- 
teractions during Odontoblast Differentiation), 
Burtin (Interactions between Tumour Cells and 
Matrix in Human Adenocarcinomas), and Bartali 
et al. (Presence and Role of Fibronectin Fragments 
in Transformed Cells). The last three of these 
chapters are especially topical and interesting. 
The title of this book appears to the reviewer to 
be rather misleading. One might assume that there 
would be an in-depth coverage of those glycopro- 
teins which have an established role in cell-matrix 
interactions and which have been the subject of 
many detailed studies, both structural and func- 
tional. Fibronectin certainly deserves much more 
attention than one short chapter (Structural 
Glycoproteins and Cell Matrix Interactions in Nor- 
mal and Pathological Conditions), and mention in 
the chapters on Odontoblast Differentiation and 
Presence and Role of Fibronectin Fragments in 
Transformed Cells. Certainly there are detailed 
reviews available and references are given but sure- 
ly the volume title demands a more comprehensive 
treatment. Exactly the same point can be made 
about laminin, which elicits thirty-six lines of text, 
about chondronectin, which is only mentioned in a 
table, and about vitronectin, which is not mention- 
ed at all. At the same time, it is difficult to see how 
the editors justify an apparently disproportionate 
allocation of space to descriptions of structural 
glycoproteins from cornea, aorta and lung, which 
remain largely uncharacterized in comparison with 
fibronectin and laminin. 
It seems to the reviewer that the word ‘struc- 
tural’ has now outlived its usefulness as an adjec- 
tive to describe glycoproteins of the connective 
tissue matrix. It is unfortunate that the result of 
the editors’ retention of this name is that the em- 
phasis in the book does not adequately reflect our 
current understanding of this area. 
J.C. Anderson 
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This compilation of research chapters focuses en- 
tirely on the molecular structure and physical pro- 
perties of the components of the interphoto- 
receptor matrix (IPM), an area of the eye which 
may have profound implications in the pathobiol- 
ogy of retinal disease. The editors have done well 
to obtain contributions from such a wide number 
of eminent members of the ophthalmic and vision 
research community. 
This book is arranged in two parts with the first 
being further subdivided. Part 1 deals with the nor- 
ma1 function of the IPM and is subdivided into 
two sections the first covering morphology and the 
second biochemistry and cell biology. The second 
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and final part of the book deals with various 
aspects of the diseased states. 
The morphology section starts with an historical 
review of the early years of research into an 
understanding of the IPM. We are then introduced 
to the modern concepts of the morphology of IPM 
as shown by rapid freezing techniques and finally 
the observation that their are domains of IPM 
material that are specifically associated with cone 
but not rod inner and outer segments. 
The biochemistry and cell biology includes 8 
chapters which attempt to describe and explain 
such complexities as the presence of IRBP and 
specific phosphodiesterases together with more 
general observations. The final section on disease 
states discusses the possible involvement of the 
IPM in retinal disease in relation to research 
findings. 
Mike Boulton 
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I must begin by confessing that I am not absolutely 
impartial in reviewing this book, since I attended 
the conference on which it is based. However, I 
have been asked to review the book on the 
(perhaps dubious) grounds that 1 did not submit a 
paper for publication in the proceedings. 
The Fourth International Conference on 
Superoxide and Superoxide Dismutase in 
Chemistry, Biology and Medicine was held in 
Rome on September lstdth, 1985. The pro- 
ceedings have thus appeared rather late, which is 
surprising since camera-ready format has been 
used. This has led to ugly differences in typeface in 
many parts of the book, despite its attractive cover 
and the good quality paper used for printed. 
I can testify that the Conference itself was ex- 
cellently organised, with many first-rate presenta- 
tions and plenty of useful discussions and 
interactions between the participants. That said, I 
must question the value of publishing the pro- 
ceedings at all. Most of this volume consists of 
short papers (usually about 5 pages) in which the 
authors summarize, with inadequate descriptions 
of methodology, data that have already appeared 
elsewhere in the literature. None of the authors 
had the space to relate their work to the field in 
general. There was no attempt o report any of the 
discussion that took place, not even a ‘state of the 
art’ summary by a chairman. Reports of the 
clinical use of superoxide dismutase to treat ar- 
thritis, radiation damage and autoimmune disease 
first appeared many years ago, and several such 
reports re-occur in the present volume. However, 
1 have yet to see a well-controlled clinical trial 
published in a leading medical journal, such as 
Lancet or New England Journal of Medicine, and 
I feel that publication anywhere of anything short 
of this should now be firmly discouraged. 
Despite my enthusiasm for the conference, and 
my high regard for the efforts of the organisers, I
cannot recommend this volume as a good buy. The 
price of approximately 12.5 pence per page of text 
makes it even less so. 
B. Halliwell 
169 
